LEADER 06331nam 2200793Ia 450 001 9910962422703321 005 20251017110108.0 010 $a1-280-22193-3 010 $a9786610221936 010 $a0-309-56306-2 010 $a0-585-14244-0 035 $a(CKB)111004366656358 035 $a(EBL)3377175 035 $a(SSID)ssj0000106674 035 $a(PQKBManifestationID)11140442 035 $a(PQKBTitleCode)TC0000106674 035 $a(PQKBWorkID)10111056 035 $a(PQKB)11713633 035 $a(MiAaPQ)EBC3377175 035 $a(Au-PeEL)EBL3377175 035 $a(CaPaEBR)ebr10068408 035 $a(CaONFJC)MIL22193 035 $a(OCoLC)923268711 035 $a(DNLM)601790 035 $a(BIP)46102022 035 $a(BIP)100754 035 $a(EXLCZ)99111004366656358 100 $a19860121d1985 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aAssessing medical technologies $ereport of a study /$fby a committee of the Institute of Medicine, Division of Health Sciences Policy, Division of Health Promotion and Disease Prevention 205 $a1st ed. 210 $aWashington, D.C. $cNational Academy Press$dc1985 215 $a1 online resource (592 pages) 300 $aOutgrowth of a conference held by the Institute of Medicine in 1980. 300 $aPrepared by the Committee for Evaluating Medical Technologies in Clinical Use. 311 0 $a0-309-03583-X 320 $aIncludes bibliographies and index. 327 $a""Assessing Medical Technologies""; ""Copyright""; ""Acknowledgments""; ""Preface""; ""PROCEDURE FOR THE STUDY""; ""AUDIENCE FOR THE STUDY""; ""Contents""; ""Summary""; ""THE SCOPE OF U.S. MEDICAL TECHNOLOGY ASSESSMENT""; ""Varieties and Expense of Assessment""; ""Federal Government""; ""Drug Industry""; ""Medical Device Industry""; ""Other Private Sector Assessment Activities""; ""Lags in Assessment""; ""Recommendations""; ""METHODS OF MEDICAL TECHNOLOGY ASSESSMENT""; ""EFFECTS OF EVALUATION ON DIFFUSION OF TECHNOLOGY""; ""Diffusion and Its Determinants"" 327 $a""Types of Evaluation That Precede Accepted Medical Practice"" ""Recommendations""; ""REIMBURSEMENT AND TECHNOLOGY ASSESSMENT""; ""Assessment in the New Era of Cost Containment""; ""Paying for Technology Assessment""; ""Recommendations""; ""MEDICAL TECHNOLOGY ASSESSMENT ABROAD""; ""Recommendations""; ""CONCLUSIONS AND RECOMMENDATIONS""; ""The Challenge""; ""Key Functions for Assessment""; ""Building a System""; ""Financing""; ""Recommendations""; ""1 Introduction""; ""POLIO""; ""SURGICAL PROCEDURE""; ""EXAMPLES OF TECHNOLOGY ASSESSMENT""; ""Electronic Fetal Monitoring"" 327 $a""Computed Tomography Scanning"" ""Drug Treatment for Hypertension""; ""Hysterectomy""; ""Medical Information System""; ""SOME LESSONS FROM THE EXAMPLES""; ""COMPREHENSIVE TECHNOLOGY ASSESSMENT""; ""DIFFERENT PARTIES, DIFFERENT AIMS IN ASSESSMENTS""; ""REFERENCES""; ""2 The Scope of U.S. Medical Technology Assessment""; ""AN OVERVIEW""; ""VARIETIES OF MEDICAL TECHNOLOGY ASSESSMENT""; ""NATIONAL EXPENDITURES FOR HEALTH RESEARCH AND DEVELOPMENT, CLINICAL TRIALS, AND TECHNOLOGY ASSESSMENT""; ""FEDERAL GOVERNMENT""; ""National Institutes of Health""; ""Office of Medical Applications of Research"" 327 $a""Food and Drug Administration"" ""Office of Technology Assessment""; ""Prospective Payment Assessment Commission""; ""Health Care Financing Administration""; ""National Center for Health Services Research and Health Care Technology Assessment""; ""Office of Health Technology Assessment""; ""National Center for Health Statistics""; ""Veterans Administration""; ""Centers for Disease Control""; ""Department of Defense""; ""DRUG INDUSTRY""; ""Drug Industry Research and Development""; ""Assessment of Drugs""; ""Expenditures for Drug Assessment""; ""MEDICAL DEVICE INDUSTRY"" 327 $a""Medical Device Industry Research and Development"" ""Assessment of Medical Devices""; ""Expenditures for Medical Device Assessment""; ""OTHER PRIVATE SECTOR ASSESSMENT ACTIVITIES""; ""Insurers""; ""Medical Associations""; ""Policy Research Groups""; ""Industry Associations""; ""Provider Institutions""; ""Academic Institutions""; ""Employers""; ""CONCLUSIONS""; ""RECOMMENDATIONS""; ""Assessment Concerns""; ""Coordination of Assessment Information""; ""Responsibility for Conduct of Assessments""; ""Evaluation of Assessment Programs""; ""Financial Support for Medical Technology Assessment""; ""Amount of Support"" 330 $aNew drugs, new devices, improved surgical techniques, and innovative diagnostic procedures and equipment emerge rapidly. But development of these technologies has outpaced evaluation of their safety, efficacy, cost-effectiveness, and ethical and social consequences. This volume, which is "strongly recommended" by "The New England Journal of Medicine" "to all those interested in the future of the practice of medicine," examines how new discoveries can be translated into better care, and how the current system's inefficiencies prevent effective health care delivery. In addition, the book offers detailed profiles of 20 organizations currently involved in medical technology assessment, and proposes ways to organize U.S. efforts and create a coordinated national system for evaluating new medical treatments and technology. 606 $aMedical care$zUnited States 606 $aTechnology assessment$zUnited States 606 $aMedical technology$zUnited States$xEvaluation 606 $aMedical care 606 $aTechnology assessment 606 $aMedical technology$xEvaluation 615 0$aMedical care 615 0$aTechnology assessment 615 0$aMedical technology$xEvaluation. 615 0$aMedical care. 615 0$aTechnology assessment. 615 0$aMedical technology$xEvaluation. 676 $a610/.28 712 02$aInstitute of Medicine (U.S.).$bDivision of Health Sciences Policy. 712 02$aInstitute of Medicine (U.S.).$bDivision of Health Promotion and Disease Prevention. 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910962422703321 996 $aAssessing medical technologies$94446696 997 $aUNINA